UniQuest, the commercialisation unit of the University of Queensland, appoints Dr Dean Moss as chief executive.

The University of Queensland’s (UQ) commercialisation arm UniQuest has announced the appointment of Dr Dean Moss as the company’s chief executive (CEO).

Dean Moss, who became acting CEO in February this year, has a long history with UQ and UniQuest. Dr Moss attained a PhD in Medicine from the University, and joined UniQuest in 2005 as general manager responsible for leadership, business development and management of the firm’s life science investments. He has been involved in raising AU$75m of investment for UniQuest’s biotech spin-outs including Coridon, Pepfactants, Q-Pharm and Vaxxas.

Outside of UQ, Dean has been either a managing director or senior manager for a range of biotech firms, including Agen Biomedical, Binax, Launch Diagnostics, AMRAD Biotech, AMRAD ICT, and United Drug. He also launched UK start-up York Medical Technologies in 2004.

Carrie Hillyard, UniQuest president, said: “Under Dean’s capable leadership, we are confident that UniQuest will continue to deliver to industry a quality suite of innovations and expertise capability from researchers at The University of Queensland.”